Related Experiment Video
Updated: Jul 9, 2026

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Retroperitoneoscopic partial nephrectomy using radiofrequency coagulation for small renal tumors.
Tomohiko Asano1, Yasunori Mizuguchi, Akio Horiguchi
1Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan. otosan@ndmc.ac.jp
Urology
|December 11, 2007
Summary
Radiofrequency coagulation (RFC) provides excellent hemostasis during laparoscopic partial nephrectomy (LPN) for small renal masses. This technique improves surgical visibility and eliminates the need for hilar clamping, enhancing the safety and efficiency of LPN.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Oncology
Background:
- Laparoscopic partial nephrectomy (LPN) adoption is hindered by a lack of reliable hemostatic techniques.
- Effective hemostasis is crucial for minimizing complications and improving outcomes in LPN.
Purpose of the Study:
- To evaluate the efficacy of radiofrequency coagulation (RFC) for achieving hemostasis during LPN.
- To assess the safety and feasibility of RFC in the context of LPN for small renal masses.
Main Methods:
- LPN was performed using a retroperitoneal approach in 11 patients with small, exophytic renal tumors.
- Radiofrequency energy was applied to coagulate the tumor margin and surrounding parenchyma.
- Tumor excision was performed with ultrasonic shears, maintaining a 0.5-cm margin.
Main Results:
- Mean operative time was 222 minutes with an average blood loss of 51 mL.
- Minimal bleeding from the renal cut surface was observed, with clear visualization of renal structures post-coagulation.
- One patient experienced a thermal burn, and another developed hydronephrosis due to pyeloureteral junction stricture; no uncontrolled bleeding or urine leakage occurred.
Conclusions:
- Radiofrequency coagulation demonstrates excellent hemostatic capability during LPN.
- RFC enhances surgical visibility and ease of operation, obviating the need for hilar clamping.
- Further research and technological advancements are necessary for applying RFC to larger or centrally located renal tumors.
